Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model
Metformin was the most prescribed antidiabetic drug in CKD patients in Korea with a low risk of MALA. Antidiabetic drug use patterns varied across CKD stages, with a notable decline in metformin use in advanced CKD and a rise in SGLT2 inhibitor prescriptions, underscoring the need for further optimized therapy.
Authors
- Sandy Jeong Rhie (ORCID: https://orcid.org/0000-0003-2554-3370)
- Sang Youl Rhee (ORCID: https://orcid.org/0000-0003-0119-5818)
- Seungwon Yang (ORCID: https://orcid.org/0000-0002-0819-2954)
- Eun Kyoung Chung (ORCID: https://orcid.org/0000-0001-9200-2799)
- Yang‐Gyun Kim
- Taemin Park
- Jae Myung (ORCID: https://orcid.org/0000-0001-9403-230X)
- Susanna Joo (ORCID: https://orcid.org/0000-0003-0304-8459)
- Su-Hyun Lee (ORCID: https://orcid.org/0000-0001-8481-4367)
- Hyeon Seok Hwang
- Seok Jun Park (ORCID: https://orcid.org/0009-0008-7087-4914)
Institutions
- Ewha Womans University (KR)
- Kyung Hee University (KR)
- Kyung Hee University Medical Center (KR)
- Kyung Hee University Hospital at Gangdong (KR)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3390/ph17101369
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kyung Hee University
- Ministry of Food and Drug Safety